Edition:
United States

Amicus Therapeutics Sees FY 2018 Revenue $75 Million To $85 Million


Wednesday, 28 Feb 2018 07:00am EST 

Feb 28 (Reuters) - Amicus Therapeutics Inc ::AMICUS THERAPEUTICS ANNOUNCES FULL-YEAR 2017 FINANCIAL RESULTS AND 2018 CORPORATE UPDATES.SEES FY 2018 REVENUE $75 MILLION TO $85 MILLION.DEVELOP AND EXPAND PRECLINICAL PIPELINE TO ENSURE AT LEAST ONE NEW CLINICAL PROGRAM IN 2019.ON TRACK TO ACHIEVE FY18 REVENUE GUIDANCE OF $75M-$85M.REITERATED FULL-YEAR 2018 REVENUE AND NET CASH SPEND GUIDANCE.CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES TOTALED $358.6 MILLION AT DECEMBER 31, 2017.FY2018 REVENUE VIEW $86.8 MILLION -- THOMSON REUTERS I/B/E/S.